These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8102123)

  • 1. Pilot study of topical dinitrochlorobenzene (DNCB) in human immunodeficiency virus infection.
    Stricker RB; Zhu YS; Elswood BF; Dumlao C; Van Elk J; Berger TG; Tappero J; Epstein WL; Kiprov DD
    Immunol Lett; 1993 Apr; 36(1):1-6. PubMed ID: 8102123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical immune modulation with dinitrochlorobenzene in HIV disease: a controlled trial from Brazil.
    Traub A; Margulis SB; Stricker RB
    Dermatology; 1997; 195(4):369-73. PubMed ID: 9529559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decrease in viral load associated with topical dinitrochlorobenzene therapy in HIV disease.
    Stricker RB; Goldberg B; Mills LB; Epstein WL
    Res Virol; 1997; 148(5):343-8. PubMed ID: 9403933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and immunologic evaluation of HIV-infected patients treated with dinitrochlorobenzene.
    Stricker RB; Elswood BF; Goldberg B; Dumlao C; Van Elk J; Henry J; Winger EE; Epstein WL
    J Am Acad Dermatol; 1994 Sep; 31(3 Pt 1):462-6. PubMed ID: 8077474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved results of delayed-type hypersensitivity skin testing in HIV-infected patients treated with topical dinitrochlorobenzene.
    Stricker RB; Goldberg B; Mills LB; Epstein WL
    J Am Acad Dermatol; 1995 Oct; 33(4):608-11. PubMed ID: 7673493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dendritic cells and dinitrochlorobenzene (DNCB): a new treatment approach to AIDS.
    Stricker RB; Elswood BF
    Immunol Lett; 1991 Aug; 29(3):191-6. PubMed ID: 1769706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical dinitrochlorobenzene in HIV disease.
    Stricker RB; Elswood BF
    J Am Acad Dermatol; 1993 May; 28(5 Pt 1):796-7. PubMed ID: 8098720
    [No Abstract]   [Full Text] [Related]  

  • 8. Topical dinitrochlorobenzene therapy in the treatment of refractory atopic dermatitis: systemic immunotherapy.
    Yoshizawa Y; Matsui H; Izaki S; Kitamura K; Maibach HI
    J Am Acad Dermatol; 2000 Feb; 42(2 Pt 1):258-62. PubMed ID: 10642682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topical immune modulation (TIM): a novel approach to the immunotherapy of systemic disease.
    Stricker RB; Goldberg B; Epstein WL
    Immunol Lett; 1997 Dec; 59(3):145-50. PubMed ID: 9419021
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunomodulatory roles of topical dinitrochlorobenzene treatment in Herpes simplex virus infection.
    Yamaji M; Shudo J
    Int Immunopharmacol; 2009 Jul; 9(7-8):984-9. PubMed ID: 19362169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Frequent infection of peripheral blood CD8-positive T-lymphocytes with HIV-1. Edinburgh Heterosexual Transmission Study Group.
    Livingstone WJ; Moore M; Innes D; Bell JE; Simmonds P
    Lancet; 1996 Sep; 348(9028):649-54. PubMed ID: 8782755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human immunodeficiency virus-1 specific and natural cellular immunity in HIV seronegative subjects with multiple sexual exposures to virus.
    Nicastri E; Ercoli L; Sarmati L; d'Ettorre G; Iudicone P; Massetti P; Vullo V; Andreoni M
    J Med Virol; 2001 Jul; 64(3):232-7. PubMed ID: 11424109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mRNA-based dendritic cell vaccination induces potent antiviral T-cell responses in HIV-1-infected patients.
    Van Gulck E; Vlieghe E; Vekemans M; Van Tendeloo VF; Van De Velde A; Smits E; Anguille S; Cools N; Goossens H; Mertens L; De Haes W; Wong J; Florence E; Vanham G; Berneman ZN
    AIDS; 2012 Feb; 26(4):F1-12. PubMed ID: 22156965
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human and simian immunodeficiency virus-infected chimpanzees do not have increased intracellular levels of beta-chemokines in contrast to infected humans.
    Ondoa P; Vereecken C; Fransen K; Colebunders R; van der Groen G; Heeney JL; Kestens L
    J Med Virol; 2003 Mar; 69(3):297-305. PubMed ID: 12526038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic effect of dinitrochlorobenzene (DNCB) on verruca plana and verruca vulgaris.
    Lee S; Cho CK; Kim JG; Chun SI
    Int J Dermatol; 1984 Nov; 23(9):624-6. PubMed ID: 6519874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Loss of viral control in early HIV-1 infection is temporally associated with sequential escape from CD8+ T cell responses and decrease in HIV-1-specific CD4+ and CD8+ T cell frequencies.
    Oxenius A; Price DA; Trkola A; Edwards C; Gostick E; Zhang HT; Easterbrook PJ; Tun T; Johnson A; Waters A; Holmes EC; Phillips RE
    J Infect Dis; 2004 Aug; 190(4):713-21. PubMed ID: 15272399
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of sodium lauryl sulphate on 2,4-dinitrochlorobenzene-induced lymph node activation.
    Cumberbatch M; Scott RC; Basketter DA; Scholes EW; Hilton J; Dearman RJ; Kimber I
    Toxicology; 1993 Jan; 77(1-2):181-91. PubMed ID: 8442013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Systemic immunomodulatory effects of topical dinitrochlorobenzene (DNCB) in rats. Activity of peripheral blood polymorphonuclear cells.
    Belij S; Popov A; Zolotarevski L; Mirkov I; Djokic J; Kataranovski D; Kataranovski M
    Environ Toxicol Pharmacol; 2012 Mar; 33(2):168-80. PubMed ID: 22222559
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of natural killer cell and T-lymphocyte counts in adults infected with human immunodeficiency virus through blood and plasma sold in the past in China and in whom infection has progressed slowly over a long period.
    Jiang Y; Shang H; Zhang Z; Diao Y; Dai D; Geng W; Zhang M; Han X; Wang Y; Liu J
    Clin Diagn Lab Immunol; 2005 Nov; 12(11):1275-9. PubMed ID: 16275940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virus burden in long-term survivors of human immunodeficiency virus (HIV) infection is a determinant of anti-HIV CD8+ lymphocyte activity.
    Ferbas J; Kaplan AH; Hausner MA; Hultin LE; Matud JL; Liu Z; Panicali DL; Nerng-Ho H; Detels R; Giorgi JV
    J Infect Dis; 1995 Aug; 172(2):329-39. PubMed ID: 7622874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.